Pharmaceutical composition for the treatment of the anemia of rh

Details Pharmaceutical composition for the treatment of the anemia of rh Pharmaceutical composition for the treatment of the anemia of rh

1986-02-03

1988-03-22

Brown, J. R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Peptide containing doai

514814, 514825, A61K 3710

Patent

active

047328894

ABSTRACT:
A pharmaceutical composition for the treatment of the anemia of rheumatoid arthritis comprising a therapeutically effective amount of human erythropoietin (EPO) in a parenterally acceptable vehicle is disclosed. Human EPO may be extracted from human urine or also be prepared by expressing in a host cell the gene coding for the amino acid sequence of human EPO.

REFERENCES:
patent: 4254095 (1981-03-01), Fisher et al.
patent: 4303650 (1981-12-01), Takezawa
Merck Index, 10th Edition, p. 533, No. 3632.
Chem. Abst., 93:161360c, 1980.
Merle et al., Clin. Pharmacul. Ther., 28:216-222, 1980.
Fisher, "Kidney Hormones", Erythropoietin, pp. 551-569, 19.

Affiliated with

Also associated with

Rating

Pharmaceutical composition for the treatment of the anemia of rh does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition for the treatment of the anemia of rh, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition for the treatment of the anemia of rh will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-442210